Inventaire - your friends and communities are your best library

Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease

Author

Richard L. Proia

2000 -

Published in: Proceedings of the National Academy of Sciences of the United States of America

Date of publication: October 1, 1994

Language: English

Main subject: Hexosaminidase A, Tay-Sachs disease

Bibliographic databases:

Cites articles 19

Date

Title

Authors

January 1, 1963

Studies in Tay-Sachs disease. II. Ultrastructure of the cerebrum
January 1, 1974

Ultrastructural studies of eight cases of fetal Tay-Sachs disease
May 1, 1977

GM2 ganglioside lysosomal storage disease in cats with beta-hexosaminidase deficiency,GM 2 Ganglioside Lysosomal Storage Disease in Cats with α-Hexosaminidase Deficiency
January 1, 1978

Response to 30 generations of selection for open-field activity in laboratory mice
January 1, 1982

Gangliosides: structure, isolation, and analysis
July 1, 1983

Activating proteins for ganglioside GM2 degradation by beta-hexosaminidase isoenzymes in tissue extracts from different species,Activating Proteins for Ganglioside GM2Degradation by β-Hexosaminidase Isoenzymes in Tissue Extracts from Different Species
August 1, 1985

Characterization of a new model of GM2-gangliosidosis (Sandhoff's disease) in Korat cats
November 1, 1985

Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant).
June 1, 1985

Evidence for two different active sites on human beta-hexosaminidase A. Interaction of GM2 activator protein with beta-hexosaminidase A.
June 1, 1988

Identification of beta-N-acetylhexosaminidase A in mouse tissues with the fluorigenic substrate 4-methylumbelliferyl-beta-N-acetylglucosamine 6-sulphate
June 16, 1989

Altering the genome by homologous recombination
January 1, 1989

Effects of concurrent manipulations of cholinergic and noradrenergic function on learning and retention in mice
January 1, 1991

Neuropathology of late onset gangliosidoses. A review
January 1, 1991

Biochemical basis of late-onset neurolipidoses,Biochemical Basis of Late-Onset Neurolipidoses
January 1, 1992

Altering genes in animals by gene targeting
March 1, 1992

Neuronal lysosomal enzyme replacement using fragment C of tetanus toxin
September 1, 1992

Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway
November 1, 1993

Gene therapy for neurologic disease
June 1, 1994

Structure and expression of the mouse beta-hexosaminidase genes, Hexa and Hexb

Article -

Welcome to inventaire

The library of your friends and communities

Learn more